Lv1
28 积分 2021-11-27 加入
Ivarmacitinib in patients with moderate to severe atopic dermatitis stratified by baseline characteristics: a post-hoc analysis of a phase 3 clinical trial
1个月前
已完结
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial
2个月前
已完结
Vunakizumab in patients with active psoriatic arthritis: a multicentre, randomized, double-blind, placebo-controlled, phase 2 study
3个月前
已完结
Efficacy and safety of vunakizumab in patients with moderate-to-severe plaque psoriasis who have a history of systemic therapies: a post hoc analysis of a phase III trial
4个月前
已完结
Carrier-free Nano-Tetrandrine (PURE-T) for Psoriasis Treatment: Significant Therapeutic Efficacy and Its Regulatory Mechanism on Stratum Corneum Inflammation
7个月前
已完结
Multi-dimensional patient-reported outcomes and quality of life at diagnosis of IBD: A population-based inception cohort study
7个月前
已完结
Global burden and cross-country inequalities in six major immune-mediated inflammatory diseases from 1990 to 2021: A systemic analysis of the Global Burden of Disease Study 2021
7个月前
已完结
Cutaneous malignancy after biologic therapy for inflammatory disease: an active comparator, retrospective cohort study
10个月前
已完结
皖公网安备34019202002308
